PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 18 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Clerodermic acid (CDA) demonstrated cytotoxic and anti-proliferation activity (IC50 value of 35 μg/mL) against A549 cells in vitro [PMID:29960020].
Hydrolates of S. nemorosa showed only partial inhibitory activity against tested Gram-positive and Gram-negative bacteria [PMID:36987013].
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 30000875 (2006) — Genome-Wide Identification and Expression Analysis of the MYB Transcription Factor Family in Salvia nemorosa. · Genes
- 2.PMID: 8983215 (1997) — Megastigmane glycosides from Salvia nemorosa. · Phytochemistry
- 3.PMID: 39738427 (2024) — Screening of native wild Salvia nemorosa populations for chemical compositions, antioxidant activity and UHPLC-HRMS profiling. · Scientific reports
- 4.PMID: 38608504 (2024) — Investigating the simultaneous effect of chitosan and arbuscular mycorrhizal fungi on growth, phenolic compounds, PAL enzyme activity and lipid peroxidation in Salvia nemorosa L. · Plant physiology and biochemistry : PPB
- 5.PMID: 36987013 (2023)